LXEO R&D to Revenue
Lexeo Therapeutics Inc · R&D to Revenue
LXEO R&D to Revenue
Latest reported0.00%period ending
LXEO FY R&D/Revenue (832.97% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
LXEO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 7,517.1254% | |
| 2,723.0537% | |
| 832.973% |